Background & Aims: The diagnosis and management of Barrett's esophagus (BE) are
controversial. We conducted a critical review of the literature in BE to provide guidance on …

Objective: To determine whether patients with Barrett esophagus who undergo antireflux
surgery differ from medically treated patients in incidence of esophageal adenocarcinoma …

Objective An international meeting was organised to develop consensus on (1) the
landmarks to define the gastro-oesophageal junction (GOJ),(2) the occurrence and …

OBJECTIVES Intestinal metaplasia (IM) and dysplasia in Barrett's esophagus are
recognized surrogates for esophageal adenocarcinoma risk. While few would argue with the …

Gastric bypass in patients with morbid obesity should be an excellent antireflux procedure,
because no acid is produced at the small gastric pouch and no duodenal reflux is present …

Background The prevalence of duodenogastroesophageal reflux (DGER) and its effect on
symptoms and oesophageal lesions in gastroesophageal reflux disease (GERD) is unclear …

Barrett esophagus (BE) and carditis with intestinal metaplasia (CIM) differ in their risk of
malignancy and implications for patient management, but are difficult to distinguish in …

BACKGROUND: Mucosal ablation and endoscopic mucosal resection have been proposed
as alternatives to surgical resection as therapy for intramucosal adenocarcinoma (IMC) of …

Aim To assess the prevalence of oesophagitis, Barrett's oesophagus (BE) and other
oesophageal mucosal abnormalities in patients with systemic sclerosis (SSc) without prior …

Barrett's oesophagus is associated with severe reflux disease and is a risk factor for
oesophageal adenocarcinoma. However, there is a lack of consensus on how to assess the …